Intracerebral Infusion of Antisense Oligonucleotides Into Prion-infected Mice

Por Nazor Friberg, Karah, Hung, Gene, Wancewicz, Ed, Giles, Kurt, Black, Chris, Freier, Sue, Bennett, Frank, DeArmond, Stephen J, Freyman, Yevgeniy, Lessard, Pierre, Ghaemmaghami, Sina, Prusiner, Stanley B
Publicado em 2012

Antisense oligonucleotide therapy for neurodegenerative disease

Por Smith, Richard A., Miller, Timothy M., Yamanaka, Koji, Monia, Brett P., Condon, Thomas P., Hung, Gene, Lobsiger, Christian S., Ward, Chris M., McAlonis-Downes, Melissa, Wei, Hongbing, Wancewicz, Ed V., Bennett, C. Frank, Cleveland, Don W.
Publicado em 2006

Cerebrospinal Fluid Defines SOD1 as a Pharmacodynamic Marker for Antisense Oligonucleotide Therapy

Por Winer, Leah, B.A., Srinivasan, Dushyanth, B.A., Chun, Seung, B.A., Lacomis, David, Jaffa, Matthew, B.A., Fagan, Anne, Holtzman, David M., Wancewicz, Ed, B.S., Bennett, C.F., Bowser, Robert, Cudkowicz, Merit, Miller, Timothy M.
Publicado em 2013